Comparing the cost-effectiveness of treatments for blood clots in cancer patients - EurekAlert

Comparing the cost-effectiveness of treatments for blood clots in cancer patients - EurekAlert
Clinical scientists with UC Davis and University of Cincinnati perform first-of-its-kind analysis showing a clear difference in cost-effectiveness of medication types for life-threatening condition
Research conducted by UC Davis Comprehensive Cancer Center and the University of Cincinnati shows that direct oral anti-coagulant (DOAC) drugs are more effective and are more cost-effective than low … [+4107 chars] Read More



Related Stories

See All